Skip to main content
OpenTrials

Clinical trial condition

Metabolism, Inborn Errors

Explore clinical trials studying Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

2,496 public trials 457 recruiting studies
Refine in advanced search Browse all conditions

Metabolism, Inborn Errors trial results

Completed

A Study Comparing The Efficacy & Safety Of Torcetrapib/Atorvastatin And Atorvastatin In Subjects With High Triglycerides

NCT00134498

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Pfizer Investigational Site Anaheim, California, United States
  • Pfizer Investigational Site Huntington Beach, California, United States
  • Pfizer Investigational Site Los Angeles, California, United States
  • Pfizer Investigational Site Orange, California, United States
View all 44 locations
View Trial Details
Completed

Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Patients With Genetic High Cholesterol Disorder

NCT00134511

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +9 more
Locations
  • Pfizer Investigational Site Boston, Massachusetts, United States
  • Pfizer Investigational Site Chicoutimi, Quebec, Canada
  • Pfizer Investigational Site Ste-Foy, Quebec, Canada
  • Pfizer Investigational Site Parktown, Johannesburg, South Africa
View Trial Details
Completed

Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia

NCT00134485

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Genetic Diseases, Inborn, +10 more
Locations
  • Pfizer Investigational Site San Diego, California, United States
  • Pfizer Investigational Site Washington D.C., District of Columbia, United States
  • Pfizer Investigational Site Lutz, Florida, United States
  • Pfizer Investigational Site Tampa, Florida, United States
View all 41 locations
View Trial Details
Completed

Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria

NCT00104260

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +9 more
Locations
  • Los Angeles, California, United States
  • Oakland, California, United States
  • New Haven, Connecticut, United States
  • Chicago, Illinois, United States
View all 13 locations
View Trial Details

Related conditions